QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (57) Citing Articles via Google Scholar Google Scholar Articles by Wacnik, P. W. Articles by Wilcox, G. L. Search for Related Content PubMed PubMed Citation Articles by Wacnik, P. W. Articles by Wilcox, G. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Pain

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 1, 2001, 21(23):9355-9366

Functional Interactions between Tumor and Peripheral Nerve: Morphology, Algogen Identification, and Behavioral Characterization of a New Murine Model of Cancer Pain

Paul W. Wacnik¹, Laura J. Eikmeier², Timothy R. Ruggles², Margaret L. Ramnaraine³, Bruce K. Walcheck², Alvin J. Beitz², and George L. Wilcox^{1, 4}

Departments of ¹ Pharmacology, ² Veterinary Pathobiology, ³ Orthopedic Surgery, and ⁴ Neuroscience, University of Minnesota Schools of Medicine and Veterinary Medicine, Minneapolis, Minnesota 55455

This paper describes a model of tumor-induced bone destruction and hyperalgesia produced by implantation of fibrosarcoma cells into the mouse calcaneus bone. Histological examination indicates that tumor cells adhere to the bone edge as early as post-implantation day (PID) 3, but osteolysis does not begin until PID 6, correlating with the development of hyperalgesia. C3H/He mice exhibit a reproducible hyperalgesia to mechanical and cold stimuli between PID 6 and 16. These behaviors are present but significantly reduced with subcutaneous implantation that does not involve bone. Systemic administration of morphine (ED₅₀ 9.0 mg/kg) dose-dependently attenuated the mechanical hyperalgesia. In contrast, bone destruction and hypersensitivity were not evident in mice implanted with melanoma tumors or a paraffin mass of similar size. A novel microperfusion technique was used to identify elevated levels of the putative algogen endothelin (ET) in perfusates collected from the tumor sites of hyperalgesic mice between PID 7 and 12. Increased ET was evident in microperfusates from fibrosarcoma tumor-implanted mice but not from melanoma tumor-implanted mice, which are not hyperalgesic. Intraplantar injection of ET-1 in naive and, to a greater extent, fibrosarcoma tumor-bearing mice produced spontaneous pain behaviors, suggesting that ET-1 activates primary afferent fibers. Intraplantar but not systemic injection of the ET-A receptor antagonist BQ-123 partially blocked tumor-associated mechanical hyperalgesia, indicating that ET-1 contributes to tumor-induced nociception. This model provides a unique approach for quantifying the behavioral, biochemical, and electrophysiological consequences of tumor-nerve interactions.

Key words: hyperalgesia; primary afferent fibers; tumor nociception; endothelin; cancer pain; tumor microperfusion

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/21239355-12$05.00/0

This article has been cited by other articles:

				D. T. Hamamoto, S. G. Khasabov, D. M. Cain, and D. A. Simone Tumor-Evoked Sensitization of C Nociceptors: A Role for Endothelin J Neurophysiol, October 1, 2008; 100(4): 2300 - 2311. [Abstract] [Full Text] [PDF]

				C. E. Constantin, N. Mair, C. A. Sailer, M. Andratsch, Z.-Z. Xu, M. J. F. Blumer, N. Scherbakov, J. B. Davis, H. Bluethmann, R.-R. Ji, et al. Endogenous Tumor Necrosis Factor {alpha} (TNF{alpha}) Requires TNF Receptor Type 2 to Generate Heat Hyperalgesia in a Mouse Cancer Model J. Neurosci., May 7, 2008; 28(19): 5072 - 5081. [Abstract] [Full Text] [PDF]

				H. Namazi A Novel Use of Botulinum Toxin to Ameliorate Bone Cancer Pain Ann. Surg. Oncol., April 1, 2008; 15(4): 1259 - 1260. [Full Text] [PDF]

				I. A. Khasabova, C. L. Stucky, C. Harding-Rose, L. Eikmeier, A. J. Beitz, L. G. Coicou, A. E. Hanson, D. A. Simone, and V. S. Seybold Chemical Interactions between Fibrosarcoma Cancer Cells and Sensory Neurons Contribute to Cancer Pain J. Neurosci., September 19, 2007; 27(38): 10289 - 10298. [Abstract] [Full Text] [PDF]

				R. Benoliel, J. Epstein, E. Eliav, R. Jurevic, and S. Elad Orofacial Pain in Cancer: Part I--Mechanisms J. Dent. Res., June 1, 2007; 86(6): 491 - 505. [Abstract] [Full Text] [PDF]

				J. G. Chichorro, A. R. Zampronio, and G. A. Rae Endothelin ETB Receptor Antagonist Reduces Mechanical Allodynia in Rats with Trigeminal Neuropathic Pain. Experimental Biology and Medicine, June 1, 2006; 231(6): 1136 - 1140. [Abstract] [Full Text] [PDF]

				P. G. Trentin, M. B. Fernandes, P. D'Orleans-Juste, and G. A. Rae Endothelin-1 causes pruritus in mice. Experimental Biology and Medicine, June 1, 2006; 231(6): 1146 - 1151. [Abstract] [Full Text] [PDF]

				Z. Zhou, G. Davar, and G. Strichartz Endothelin-1 (ET-1) Selectively Enhances the Activation Gating of Slowly Inactivating Tetrodotoxin-Resistant Sodium Currents in Rat Sensory Neurons: A Mechanism for the Pain-Inducing Actions of ET-1 J. Neurosci., August 1, 2002; 22(15): 6325 - 6330. [Abstract] [Full Text] [PDF]

				D. M. Cain, P. W. Wacnik, M. Turner, G. Wendelschafer-Crabb, W. R. Kennedy, G. L. Wilcox, and D. A. Simone Functional Interactions between Tumor and Peripheral Nerve: Changes in Excitability and Morphology of Primary Afferent Fibers in a Murine Model of Cancer Pain J. Neurosci., December 1, 2001; 21(23): 9367 - 9376. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help